Project Grant R21AI182872

Award Date 6/11/24
Completion Date 4/30/26
Dollars Obligated $1.1M
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98109, USA
Similar Awards
This $465,756 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) aims to improve protein function annotation and prediction through a community-driven effort. The project will: Sustain and enrich the Critical Assessment of Functional Annotation (CAFA) community of practice by increasing engagement with biocurators and computer scientists and incentivizing open-source software development....
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $202,274 to develop an easy-to-use computer program for predicting the structure and degrading efficiency of proteolysis targeting chimeras (PROTACs). PROTACs are heterobifunctional molecules that induce the degradation of target proteins by recruiting them to E3 ubiquitin ligases. The awarded project aims to implement a...
This $800,000 Project Grant, awarded by the National Science Foundation (NSF) Biological Sciences (CFDA 47.074) program, supports research to study the generation, maintenance, and function of extrachromosomal DNA (eDNA) in the malaria parasite Plasmodium. Key objectives include evaluating the connections between chromosomal genes and eDNA, the propensity for eDNA diversity, the cellular pathways and sequences contributing to eDNA generation and stability, and the clustering of eDNA within the...
This National Science Foundation project grant of $248,782 awarded on March 15, 2022 will fund the development of computational tools and a database for understanding intrinsically disordered protein-protein and protein-nucleic acid interactions through February 28, 2025. Funded under the Biological Sciences program (CFDA 47.074), Purdue University will create three interlocking computational methods at the 1D, 2D, and 3D levels to advance prediction and modeling of tertiary structures for...
This $364,324 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 26, 2024. The grant's objective is to identify the genetic and molecular mechanisms underlying resistance to the anthelmintic drug emodepside, which is used to treat parasitic nematode infections in humans and livestock. Using the model organism Caenorhabditis elegans, the grant funds research to: 1)...
This $1,108,345 federal Project Grant award, funded by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), supports research to characterize the evolutionary transition of host-microbe interactions from commensal symbionts to blood parasites in apicomplexan organisms, which include the parasites that cause malaria. The project, led by the University of Rhode Island, will use advanced microscopy and genomics to compare the cellular invasion machinery between...
This $147,656 federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the role of transmembrane proteins in the cell division process of the malaria parasite Plasmodium falciparum. The award, effective January 22, 2025 through October 31, 2027, will enable the integration of biochemical and super-resolution microscopy approaches to decipher...
This $1,205,737.49 Project Grant awarded by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172) supports the development of scalable computational methods and software tools to enable better analysis and interpretation of large genomic datasets. The key objectives are to: Develop a novel maximum likelihood estimation framework and optimization techniques to significantly accelerate phylogenetic analysis and enable the use of more complex...
The federal Project Grant award of $459,131, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program, supports research to identify essential functions of the mitochondrion in malaria parasites. The goal is to uncover novel drug targets within the parasite mitochondrion that could lead to the development of new antimalarial treatments effective against both symptomatic and transmission stages of malaria...
This three-year, $388,229 National Science Foundation project grant supports research assessing the systematics and diversity of haemoporidia in African lizards. The primary awardee, Villanova University, will collaborate with sub-awardee University of Michigan-Dearborn on generating reptile genetic data, preliminary vector screening, and phylogenetic analyses to advance understanding of haemoporidia species delimitation and the processes driving their diversity across host clades and biomes....

A STRUCTURE-BASED ORTHOLOGY APPROACH TO PREDICT PROTEIN FUNCTION IN EUKARYOTIC PARASITES - PROJECT SUMMARY EUKARYOTIC PARASITES ARE A DIVERSE GROUP OF ORGANISMS THAT CAN CAUSE A WIDE RANGE OF INFECTIOUS DISEASES IN HUMANS. THESE DISEASES HAVE A SIGNIFICANT IMPACT ON GLOBAL HEALTH, WITH MILLIONS OF PEOPLE AFFECTED ANNUALLY. THE ADVENT OF AFFORDABLE GENOME SEQUENCING HAS REVOLUTIONIZED THE STUDY OF PATHOGENS FOR THERAPEUTIC DEVELOPMENT. HOWEVER, THE FUNCTIONAL ANNOTATION OF THE PROTEINS ENCODED BY THESE GENOMES HAS STRUGGLED TO KEEP PACE WITH THE RAPID ADVANCEMENTS IN SEQUENCING TECHNOLOGY. TRADITIONAL METHODS BASED ON SEQUENCE ORTHOLOGY HAVE FAILED TO FULLY ANNOTATE A THIRD OF ALL PROTEINS IN VEUPATHDB, A SEQUENCE DATABASE DEDICATED TO EUKARYOTIC PARASITES AND A BIOINFORMATICS RESOURCE CENTERS (BRCS) PROJECT FUNDED BY THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID). TO OVERCOME THIS CHALLENGE, WE PROPOSE TO APPLY A NOVEL STRUCTURE-BASED ORTHOLOGY APPROACH TO PREDICT PROTEIN FUNCTION. THIS APPROACH RELIES ON ALPHAFOLDDB, A VAST REPOSITORY OF PRECOMPUTED MODELS, AND FOLDSEEK, A REVOLUTIONARY ALGORITHM THAT ALIGNS STRUCTURES WITH HIGH ACCURACY AND SPEED, COMBINED WITH ORTHOMCL SEQUENCE ORTHOLOGY. THE SUCCESSFUL COMPLETION OF THIS PROJECT HAS THE POTENTIAL TO BE A GAME-CHANGER IN INFECTIOUS DISEASE RESEARCH. THE ABILITY TO FUNCTIONALLY ANNOTATE THOUSANDS OF UNCHARACTERIZED PROTEINS IN VEUPATHDB WILL PROVIDE A VALUABLE TOOL FOR IDENTIFYING POTENTIAL TARGETS FOR FURTHER FUNCTIONAL STUDIES AND THERAPEUTIC DEVELOPMENT. FURTHERMORE, THE ABILITY TO AUTOMATE THIS PROCESS REPRESENTS A SIGNIFICANT ADVANCEMENT OVER THE CURRENT MANUAL PROCESS, WHICH REQUIRES EXTENSIVE STRUCTURAL BIOLOGY KNOWLEDGE. SPECIFIC AIMS: 1) DEFINE DOMAIN-BASED STRUCTURE ORTHOLOGY GROUPS (DSOGS) AT SCALE BY LEVERAGING ALPHAFOLDDB AND FOLDSEEK TO IDENTIFY STRUCTURAL ORTHOLOGS AND RANK THEM BASED ON CONSERVATION OF POSITIONS IN STRUCTURE-BASED SEQUENCE ALIGNMENTS. 2) PREDICT THE FUNCTION OF DSOGS AT SCALE WITH NATURAL LANGUAGE PROCESSING TECHNIQUES, SUCH AS PROTNLM, TO GENERATE UNIFIED NAMES AND FUNCTIONAL ANNOTATIONS FOR PROTEINS WITH SIMILAR FUNCTIONS WITHIN DSOGS. WE WILL COLLABORATE WITH VEUPATHDB TO UPDATE EXISTING OFFICIAL PRODUCT NAMES AND ANNOTATIONS. BY SUCCESSFULLY COMPLETING THESE SPECIFIC AIMS, OUR PROJECT WILL DELIVER ANNOTATIONS FOR THOUSANDS OF UNCHARACTERIZED PROTEINS IN VEUPATHDB AS WELL AS AN AUTOMATED PIPELINE THAT STREAMLINES THE LABORIOUS PROCESS OF PROTEIN FUNCTIONAL ANNOTATION. THE ANNOTATIONS WILL PROVIDE VALUABLE INSIGHTS INTO THE BIOLOGY OF PARASITIC ORGANISMS, HELP IDENTIFY POTENTIAL TARGETS FOR FURTHER FUNCTIONAL STUDIES, AND FACILITATE THE DEVELOPMENT OF NOVEL THERAPEUTIC INTERVENTIONS FOR INFECTIOUS DISEASES.

Posted 6/11/24, 12:00 AM